More than 25% of head and neck squamous cell carcinomas (HNSCC) and 99% of cervical cancers (CxCa) are positive for high-risk human papillomaviruses (HPVs). Furthermore, the type I tyrosine kinase receptor ErbB-2 is overexpressed in at least 30% of HNSCC and CxCa. Recently, we demonstrated that E6/E7 of HPV type 16 cooperate with ErbB-2 to induce cell transformation of human normal oral epithelial (NOE) cells. This is accompanied by overexpression of cyclin D1 in NOE cells. To determine the role of cyclin D1 in E6/E7/ErbB-2 cooperation, we examined the independent effects of E6/E7 and ErbB-2, and the combined effect of E6/E7 and ErbB-2 in mouse normal embryonic fibroblast (NEF), wild type (wt), and knockout cyclin D1 (D1 À/À ) cells. We report that NEF-wt cells transduced with E6/E7 alone and E6/E7/ErbB-2 together form small and large tumors in nude mice, respectively, as well as different sized colonies in soft agar; whereas ErbB-2 alone elicits neither tumor formation in vivo nor colony formation in soft agar. More importantly, E6/E7, ErbB-2 and E6/E7/ErbB-2 together all fail to induce neoplastic transformation of cyclin D1 À/À cells in vivo and in vitro. Furthermore, using antisense cyclin D1 we completely inhibited tumor and colony formation of NEF-wt-E6/E7 and wt-E6/E7-ErbB-2 as well as human NOE-E6/E7-ErbB-2-transformed cells. These analyses reveal that cyclin D1 is the downstream target of the neoplastic transformation induced by E6/E7 or E6/E7/ErbB-2 cooperation in normal cells. Our data suggest that anti-cyclin D1 therapy may be highly specific in the treatment of all human cancers expressing high-risk HPVs or HPVs/ErbB-2.
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Keywords: cyclin D1; E6/E7 of HPV; ErbB-2; cell transformation Head and neck (HN) cancer is the sixth most common neoplasm in the world today in both men and women (Gasco and Crook, 2003) . Cervical carcinoma (CxCa) is the second most common cancer among women worldwide and the most frequent female cancer in large areas of the developing world (Clifford et al., 2003) . The overall 5-year survival rate of patients diagnosed with HN cancer or CxCa is approximately 60% and has not significantly improved over the past two decades. An important etiological factor is the human papillomavirus (HPV), as roughly 25% of HN cancers and 99% of CxCa are positive for high-risk HPVs (types 16 and 18) (Ke et al., 1999; Gillison et al., 2000; Niv et al., 2000; Moreno et al., 2002) . The high-risk HPV E6 and E7 oncoproteins, which are constitutively expressed in these cancers, inactivate the p53 and pRb tumor suppressors, respectively. However, HPV infection alone is not sufficient for neoplastic progression in humans; the HPV-infected cell must undergo additional genetic changes. Moreover, the type I tyrosine kinase receptor ErbB-2 is overexpressed in at least 30% of HN cancers and CxCa (Xia et al., 1997; Wilkman et al., 1998; Ibrahim et al., 1999; Lee et al., 2002) . No studies have been performed that address the potential importance of the combined effect of HPV and ErbB-2 in HN cancer.
Earlier studies reported that cyclin D1, D2 and D3 family members of D-type cyclins are overexpressed in different types of human cancer (Almadori et al., 2002; Decker et al., 2002; Liu et al., 2002) . D-type cyclins collectively control cell-cycle progression by activating their cyclin-dependent kinase partners, CDK4 and CDK6, which leads to phosphorylation of the retinoblastoma protein, and, in turn, advancement through the G1 phase of the cell cycle (Sherr and Roberts, 1999).
Cyclin D1 is a commonly overexpressed D-type cyclin in human carcinomas, including cervical cancer, oral epithelial dysplasia and invasive carcinomas (Cheung et al., 2001; Rousseau et al., 2001; Almadori et al., 2002) . Using a knockout model, Sicinski et al. (1995) reported that mice lacking cyclin D1 display several distinct tissue-specific phenotypes, including severely hypoplastic retinas, and fail to undergo normal mammary epithelial development during pregnancy. Furthermore, they demonstrated that the cyclin D1 gene is a target of cell transformation induced by Ras/Neu (rat ErbB-2) cooperation . Recently, we reported that E6/E7 of HPV type 16 cooperated with the ErbB-2 receptor to induce cell transformation and the deregulation of E-cadherin/catenin complex of human normal oral epithelial cells (NOE); we also demonstrated that E6/E7/ErbB-2 cooperation induced a nuclear translocation of b-catenins. In contrast, ErbB-2 or E6/E7 alone did not affect either cell transformation or E-cadherin/catenin regulation patterns, including b-catenin localization in NOE cells (Al Moustafa et al., 2004) . Earlier studies reported that cyclin D1 is a target of nuclear b-catenin, via interaction with T-cell factor (Tcf) or lymphoid enhancer factor (Lef) (Shtutman et al., 1999; Lin et al., 2000) . Interestingly, we found that E6/E7/ErbB-2 cooperation induced cyclin D1 expression in NOE cells (Al Moustafa et al., 2004) . Because of this result, we speculated that the oncogenic effect of E6/E7/ErbB-2 might be mediated, at least in part, through regulation of cyclin D1.
To determine the role of cyclin D1 in cell transformation induced by E6/E7/ErbB-2 cooperation, we examined the effect of E6/E7, ErbB-2 and E6/E7/ErbB-2 together in mouse normal embryonic fibroblast (NEF), wild type (wt), and embryonic knockout cyclin D1 (D1 À/À ) cells (Sicinski et al., 1995) . In parallel, we studied the effect of antisense cyclin D1 in human NOE cells transformed by E6/E7/ErbB-2 cooperation. We transduced mouse normal embryonic fibroblast cyclin
) and mouse embryonic fibroblast wt (NEF-wt) cells with E6/E7 of HPV type 16 and ErbB-2 singly and in combination using recombinant retroviral systems as described previously (Al Moustafa et al., 2004) . To study the effect of E6/E7, ErbB-2 and E6/E7/ ErbB-2 together, we utilized polyclonal populations of NEF-wt and NEF-D1 À/À cells. We found that NEF-wtErbB-2, NEF-wt-E6/E7-ErbB-2, NEF-D1 À/À -ErbB-2-, and NEF-D1 À/À -E6/E7-ErbB-2 cells overexpress ErbB-2; whereas NEF-wt, NEF-wt-E6/E7, NEF-D1 À/À and NEF-D1 À/À -E6/E7 cells do not. Furthermore, only the NEF-wt and NEF-D1 À/À cell lines transduced by the E6/E7 retrovector express these genes (data not shown). Also, we reported that NEF-wt-E6/E7 and NEF-wt-E6/ E7-ErbB-2 overexpress cyclin D1 in comparison with NEF-wt and NEF-ErbB-2 cells (Figure 1 ). In contrast, NEF-D1
and NEF-D1 À/À -E6/E7-ErbB-2 do not express cyclin D1, as expected ( Figure 1 ). Next, we investigated the transforming ability of NEF-wt, NEF-D1 À/À cells and those expressing E6/E7, ErbB-2 and E6/E7/ErbB-2 together in vitro and in vivo. E6/E7 and E6/E7/ErbB-2 induce cell transformation of NEF-wt cells but ErbB-2 does not. More importantly, E6/E7, ErbB-2 and E6/E7/ ErbB-2 together do not induce cell transformation of NEF-D1 À/À cells ( Figure 2a and Table 1 ). Therefore, 4-5% of NEF-wt-E6/E7 and 25-30% of NEF-wt-E6/ E7-ErbB-2 cells are able to form small and large colonies, respectively, in soft agar (Figure 2a, b) . Furthermore, we examined tumor formation in nude mice of all NEF-wt and NEF-D1 À/À cells. We injected, in total, 25 nude mice with NEF-wt and NEF-D1 À/À cells, and with those expressing E6/E7, ErbB-2 and E6/ E7/ErbB-2 together (Table 1) . We found that 100% of the mice injected with NEF-wt-E6/E7 form small tumors within 10 days while those injected with NEF-E6/E7-ErbB-2 cells form large tumors in the same time period (Table 1 ). The contribution of E6/E7 of HPV 16 and HPV 18 to carcinogenesis in mice has been confirmed by the use of transgenic mouse models À/À cells expressing E6/E7, ErbB-2 and/or E6/E7/ ErbB-2. NEF-wt and NEF-ErbB-2 cells express low levels of cyclin D1; whereas NEF-E6/E7 and NEF-E6/E7-ErbB-2 cells demonstrate high levels of cyclin D1 expression. However, we note that NEF-E6/E7-ErbB-2 cells express higher levels of cyclin D1 than NEF-E6/E7 cells. In addition, NEF-D1 À/À , NEF-D1 À/À -E6/E7, NEF-D1 À/À -ErbB-2 and NEF-D1 À/À -E6/E7-ErbB-2 cells do not express cyclin D1, as expected. We used GAPDH expression to control for the amounts of proteins in the samples. The Western blot analysis was performed using anti-cyclin D1 anti-sera (sc-717, Santa Cruz Biotechnology) and monoclonal antibody (mAb) (Clone SP4, Lab Vision Co.), anti-GAPDH (clone 6C5, Cedarlane) and anti-actin (clone C4, Roche Diagnostics) mAbs as previously described (Al Moustafa et al., 2004) E6/E7/ErbB-2-induced transformation is dependent on cyclin D1 regulation A-E Al Moustafa et al (Eckert et al., 2000; Carraresi et al., 2001) . In contrast, we observed that NEF-D1
À/À -ErbB-2 and NEF-D1 À/À -E6/E7-ErbB-2 cells are not able to form any tumors in nude mice (Table 1 ). In conclusion, NEF-wt-E6/E7 cells are mildly tumorigenic, NEF-wt-E6/E7/ErbB-2 and NOE-E6/E7/ErbB-2 cells are highly tumorigenic, and NOE-E6/E7 and NOE-ErbB-2 (Al Moustafa et al., 2004) , NEF-ErbB-2, NEF-D1
À/À -ErbB-2 and NEF-D1
À/À -E6/E7/ErbB-2 cells are not tumorigenic. Furthermore, histological analysis of NEF-wt-E6/E7 and NEF-wt-E6/E7-ErbB-2 tumors from nude mice confirmed the presence of a high-grade malignancy (Figure 3a) . We also found that by RT-PCR analysis, NEF-wt-E6/E7 and NEF-wt-E6/ E7-ErbB-2 tumors expressed E6/E7 (data not shown). More importantly, the E6/E7-ErbB-2 tumors had an enhanced expression of both cyclin D1 and ErbB-2 in comparison with E6/E7 tumors (Figure 3b, c) . These data suggest that cyclin D1 is the downstream target of the cell transformation induced by E6/E7 and E6/E7/ ErbB-2 cooperation in NEFs. Earlier studies reported that antisense cyclin D1 (AD1) led to the inhibition of cyclin D1 expression and cell growth of squamous cell carcinomas both in vitro and in vivo (Sauter et al., 1999 (Sauter et al., , 2000 (Sauter et al., , 2002a . To determine and confirm the role of cyclin D1 in human oral epithelial and NEF cells, transformed by E6/E7/ErbB-2 cooperation, we transduced NOE and NEF cells, expressing E6/E7 and E6/ E7/ErbB-2 together, with AD1 and LacZ (control) adenovirus as described (Sauter et al., 1999 (Sauter et al., , 2000 . We found that AD1 suppressed cyclin D1 protein expression in comparison with the control cells (data not shown), and cells treated with AD1 failed to form tumors in nude mice within 1 month and colonies in soft agar after 3 weeks (Table 1 and Figure 2a, b) . In contrast, NOE-E6/E7-ErbB-2, NEF-wt-E6/E7 and NEF-wt-E6/E7-ErbB-2 but not NOE-E6/E7 cells, treated/untreated with LacZ adenovirus, elicited colonies and tumors within 3 weeks and 10 days, respectively [Table 1 and Previous studies have found that cyclin D1 is the downstream target of Ras/Neu cooperation in mammary epithelial malignant transformation in vivo; whereas, in fibroblast cells, Ras/Neu induced malignant transformation in the absence of cyclin D1 . Moreover, Robles et al. (1998) 
demonstrated that cyclin D1
À/À mice remain susceptible to Ras-driven skin papillomas; although the number of skin tumors per À/À and NOE cells expressing E6/E7, ErbB-2 and E6/E7/ErbB-2 together in vitro. (a) Transforming effect of E6/E7, ErbB-2 and E6/E7/ErbB-2 together in NEF-wt, NEF-D1 À/À and NOE cells in vitro. We examined the colony formation of NEF-wt, NEF-D1 À/À and NOE cells expressing E6/E7, ErbB-2 and E6/E7/ErbB-2 together in soft agar. We found 4-5% of NEF-E6/E7 and 25-30% of NEF-E6/E7/ErbB-2 and NOE-E6/E7/ErbB-2 cells form colonies; while NEF-wt, NEF-ErbB-2, NOE, NOE-E6/E7 and NOE-ErbB-2 cells do not from any colonies. More importantly, NEF-D1 À/À expressing E6/E7, ErbB-2 and/or E6/E7/ErbB-2 all failed to form colonies in soft agar. E6/E7 and E6/E7/ErbB-2 have significant transforming effects in NEF and NOE cells in comparison with their wt cells (Po0.0001). Also, we studied the effect of antisense cyclin D1 (AD1) and LacZ adenovirus (as control) in NEF-wt and NOE cells expressing E6/E7 and/or E6/E7/ErbB-2. The cells treated with AD1 failed to form colonies in soft agar after 3 weeks. In contrast, NOE-E6/E7-ErbB-2, NEF-wt-E6/E7-ErbB-2 and NEF-wt-E6/E7 but not NOE-E6/E7 cells, treated/untreated with LacZ adenovirus, elicited colonies within 3 weeks. Note that LacZ adenovirus did not affect significantly colony formation numbers of NEF-E6/E7 and NEF-E6/E7/ErbB-2 transformed cells, in comparison with untreated cells (P ¼ 0.695 and 0.111). The AD1 and LacZ adenovirus were generated in Dr Herlyn's laboratory (The Wistar Institute, Philadelphia, PA, USA) (Sauter et al., 1999) . Briefly, 20-mer primers designed to amplify cyclin D1 were PCR-amplified for 35 cycles. The 1.1-kb product including the entire cyclin D1 open reading frame was inserted into the shuttle vector pAd.CMV-Link.1 (University of Pennsylvania Vector Core). pAd.CMV-Link1 was then cotransfected into 293 cells with adenoviral DNA lacking the E1 and E3 regions using calcium phosphate precipitation. Homologous recombination between pAd.CMVl-LINK.1 and dl7001, resulting in the incorporation of cyclin D1 into the adenoviral backbone, led to a cytopathic effect as evidenced by plaque formation after approximately 2 weeks. The virus was purified by cesium chloride centrifugation and dialysed against PBS before use. Approximately 1 Â 10 5 cells of each cell line were transduced for 24 h in vitro by AD1 and LacZ (control) adenovirus as described by Sauter et al. (1999 Sauter et al. ( , 2000 . A total of 2000 of the transduced cells and their wt cells were placed in RPMI medium containing 10% fetal bovine serum and 0.4% agar and were plated over a layer of RPMI medium containing 10% FBS and 0.7% agar. The cultures were examined every 1-2 days for 3 weeks. (b) Colony formation ability of NEF-wt-E6/E7 and NEF-wt-E6/E7-ErbB-2 cells in vitro. NEF-wt-E6/E7 and NEF-wt-E6/E7-ErbB-2 cells are able to form small and large colonies in soft agar, respectively. In contrast, AD1 inhibits the colony formation ability of these cells in soft agar. Magnification is Â 100 E6/E7/ErbB-2-induced transformation is dependent on cyclin D1 regulation A-E Al Moustafa et al mouse was lower in cyclin D1 À/À mice than in the wt animal. Using our NOE and NEF cells, we were able to demonstrate that cyclin D1 is essential for the cell transformation induced by E6/E7/ErbB-2 cooperation in both human and mouse cells. Furthermore, we report that cyclin D1 is the target of cell transformation induced by E6/E7 of HPV type 16 in mouse embryonic fibroblast cells and abolishing cyclin D1 expression negates the transformation ability of HPV in these cells. Recently, we demonstrated that cyclin D1 is the target of E6/E7/ErbB-2 cooperation in NOE-transformed cells via conversion of the role of b-catenin from a cell-cell adhesion molecule to a transcriptional regulator (Al Moustafa et al., 2004) . In NEF-E6/E7 and NEF-E6/E7/ ErbB-2 transformed cells but not NEF cells, we found that b-catenin is trans-localized from the cytoplasm to the nucleus (data not shown). Thus, the cyclin D1 overexpression in those mouse transformed cells could be the result of the nuclear b-catenin via its interaction with Tcf or Lef family of transcription factors (Shtutman et al., 1999; Lin et al., 2000; Al Moustafa et al., 2004) . Our data suggest that anti-cyclin D1 therapy may be highly specific in the treatment of all human cancers expressing high-risk HPVs or a combination of HPVs and ErbB-2 through regulation of cell cycle checkpoints progression. Figure 3 Histological and immunohistochemical analyses of NEF-wt-E6/E7 and NEF-wt-E6/E7-ErbB-2 tumors. Hematoxylin and eosin histology, and immunohistochemical analyses for cyclin D1 and ErbB-2 of tumors derived from NEF-wt-E6/E7 and NEFwt-E6/E7-ErbB-2 cells were performed as previously described (Al Moustafa et al., 2004) except that anti-cyclin D1 mAb (Clone SP4, Lab Vision Co.) was used for the immunohistochemistry analysis. Routine histology shows a high-grade carcinoma (a) overexpressing cyclin D1 and ErbB-2 as immunolabeled with anti-cyclin D1 (b) and anti-ErbB-2 mAbs (c). Magnification is Â 200 Table 1 Tumor formation ability of NEF-wt, NEF-D1 À/À and NOE cells expressing E6/E7, ErbB-2 and E6/E7/ErbB-2 together in vivo. NEF-wt, NEF-ErbB-2, NOE, NOE-E6/E7, NOE-ErbB-2, NEF-D1 À/À , NEF-D1 À/À -E6/E7, NEF-D1 À/À -ErbB-2 and NEF-D1 À/À -E6/ E7-ErbB-2 cells failed to form tumors in nude mice within 1 month. In contrast, NEF-wt-E6/E7, NEF-wt-E6/E7-ErbB-2 and NOE-E6/E7/ ErbB-2 cells form tumors in nude mice within 10 days. In parallel, NEF-wt-E6/E7, NEF-wt-E6/E7-ErbB-2 and NOE-E6/E7/ErbB-2 cells transduced with LacZ adenovirus were able to form tumors also within 10 days; whereas treatment with AD1 adenovirus completely inhibits the tumor formation of NEF-wt-E6/E7-AD1 and NEF-wt-E6/E7-ErbB-2-AD1 cells when transplanted into nude mice and observed for 1 month. Approximately 2 Â 10 6 cells of each cell line were treated for 24 h in vitro with AD1 and LacZ adenovirus as described by Sauter et al. (1999 Sauter et al. ( , 2000 . Cell lines were resuspended in PBS and injected subcutaneously in the flank region (2 Â 10 6 per 0.1 ml) of BALB/c (nu/ nu) mice. Experimental animals were cared for in accordance with McGill University Animal care guidelines E6/E7/ErbB-2-induced transformation is dependent on cyclin D1 regulation A-E Al Moustafa et al
